Simone Feurstein

991 total citations
18 papers, 333 citations indexed

About

Simone Feurstein is a scholar working on Hematology, Genetics and Genetics. According to data from OpenAlex, Simone Feurstein has authored 18 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Genetics and 7 papers in Genetics. Recurrent topics in Simone Feurstein's work include Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Simone Feurstein is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). Simone Feurstein collaborates with scholars based in United States, Germany and Australia. Simone Feurstein's co-authors include Lucy A. Godley, Michael W. Drazer, Jeremy Segal, Christopher N Hahn, Madina Sukhanova, Xi Luo, Sabah Kadri, Gudrun Göhring, Caroline Weipert and Christopher K. Daugherty and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Simone Feurstein

18 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simone Feurstein United States 10 249 116 95 81 76 18 333
Audrey Basinko France 13 242 1.0× 118 1.0× 119 1.3× 217 2.7× 108 1.4× 33 512
Iléana Antony‐Debré France 8 209 0.8× 96 0.8× 49 0.5× 97 1.2× 43 0.6× 15 300
Paola Maria Cavigliano Italy 12 324 1.3× 136 1.2× 63 0.7× 94 1.2× 69 0.9× 27 384
Matthew Smith United Kingdom 4 222 0.9× 90 0.8× 40 0.4× 162 2.0× 52 0.7× 8 306
Laurence Baranger France 12 244 1.0× 104 0.9× 49 0.5× 110 1.4× 114 1.5× 19 362
Barbara Rocca Italy 9 274 1.1× 127 1.1× 48 0.5× 86 1.1× 52 0.7× 21 310
Jane Churpek United States 6 125 0.5× 60 0.5× 131 1.4× 78 1.0× 48 0.6× 10 287
Liat Rainis Israel 5 295 1.2× 69 0.6× 63 0.7× 217 2.7× 132 1.7× 6 419
Magda Šišková Czechia 10 344 1.4× 131 1.1× 57 0.6× 123 1.5× 32 0.4× 22 395
V. Parlier Switzerland 13 383 1.5× 144 1.2× 76 0.8× 121 1.5× 100 1.3× 19 446

Countries citing papers authored by Simone Feurstein

Since Specialization
Citations

This map shows the geographic impact of Simone Feurstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Feurstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Feurstein more than expected).

Fields of papers citing papers by Simone Feurstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Feurstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Feurstein. The network helps show where Simone Feurstein may publish in the future.

Co-authorship network of co-authors of Simone Feurstein

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Feurstein. A scholar is included among the top collaborators of Simone Feurstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Feurstein. Simone Feurstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Trottier, Amy M., Simone Feurstein, & Lucy A. Godley. (2024). Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders. Best Practice & Research Clinical Haematology. 37(1). 101537–101537. 5 indexed citations
2.
Feurstein, Simone. (2023). Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle. Frontiers in Oncology. 13. 1128533–1128533. 4 indexed citations
3.
Feurstein, Simone, Jessica K. Holien, Sionne E. M. Lucas, et al.. (2022). Functional genomics for curation of variants in telomere biology disorder associated genes: A systematic review. Genetics in Medicine. 25(3). 100354–100354. 4 indexed citations
4.
Feurstein, Simone, Christopher N Hahn, Nikita Mehta, & Lucy A. Godley. (2022). A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias. Genetics in Medicine. 24(4). 931–954. 9 indexed citations
5.
Feurstein, Simone, et al.. (2022). Revision of RUNX1 variant curation rules. Blood Advances. 6(16). 4726–4730. 7 indexed citations
6.
Kubota, Yasuo, Jibran Durrani, Wenyi Shen, et al.. (2022). Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia. Leukemia. 36(12). 2827–2834. 8 indexed citations
7.
Feurstein, Simone, Constantin Schwab, Iris Breitkreutz, et al.. (2022). Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report. SHILAP Revista de lepidopterología. 3(4). 1377–1380. 2 indexed citations
8.
Homan, Claire C., Parvathy Venugopal, Peer Arts, et al.. (2021). GATA2 deficiency syndrome: A decade of discovery. Human Mutation. 42(11). 1399–1421. 29 indexed citations
9.
Hahn, Christopher N, Simone Feurstein, Deepak Singhal, et al.. (2021). Unexpected High Frequency of Pathogenic Germline Variants in Older Adults with Primary Myelodysplastic Syndrome. Blood. 138(Supplement 1). 2594–2594. 1 indexed citations
10.
Feurstein, Simone, Michael W. Drazer, & Lucy A. Godley. (2021). Germline predisposition to hematopoietic malignancies. Human Molecular Genetics. 30(R2). R225–R235. 22 indexed citations
12.
Trottier, Amy M., Lawrence J. Druhan, Ira L. Kraft, et al.. (2020). Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies. Blood Advances. 4(20). 5269–5284. 19 indexed citations
13.
Feurstein, Simone, Kathrin Thomay, Winfried Hofmann, et al.. (2018). Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion. International Journal of Molecular Sciences. 19(10). 3269–3269. 6 indexed citations
14.
Drazer, Michael W., Sabah Kadri, Madina Sukhanova, et al.. (2018). Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Advances. 2(2). 146–150. 65 indexed citations
15.
Feurstein, Simone & Lucy A. Godley. (2017). Germline ETV6 mutations and predisposition to hematological malignancies. International Journal of Hematology. 106(2). 189–195. 54 indexed citations
16.
Feurstein, Simone, Michael W. Drazer, & Lucy A. Godley. (2016). Genetic predisposition to leukemia and other hematologic malignancies. Seminars in Oncology. 43(5). 598–608. 43 indexed citations
17.
Feurstein, Simone, Frank G. Rücker, Lars Bullinger, et al.. (2014). Haploinsufficiency of ETV6 and CDKN1B in patients with acute myeloid leukemia and complex karyotype. BMC Genomics. 15(1). 784–784. 21 indexed citations
18.
Tauscher, Marcel, Gudrun Göhring, Stefanie Glaser, et al.. (2010). Clonal heterogeneity in childhood myelodysplastic syndromes—Challenge for the detection of chromosomal imbalances by array‐CGH. Genes Chromosomes and Cancer. 49(10). 885–900. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026